MedStar Union Memorial Hospital is a non-profit, acute care teaching hospital located in the North Central section of Baltimore, Maryland. The hospital is a member of MedStar Health, a community-based network of Baltimore/Washington, D.C. area hospitals and other health care services.In 2014, the magazine U.S. News & World Report ranked the hospital 10th in Maryland, and 9th in the Baltimore metropolitan area. For cardiology, cardiac surgery, and orthopedic surgery, it is ranked[by whom?] among the top 50 hospitals in the U.S..[citation needed]Jazz leader Chick Webb worked in the hospital as a youngster, and Mickey Mantle received treatment at the hospital. In 1939, the gangster Al Capone spent time at the hospital to cure his paresis caused by syphilis, after his release from Alcatraz, after which he donated two cherry trees to the hospital. One tree was later cut down to allow the construction of a new wing of the hospital..
Purpose Depression is a known comorbidity in patients with chronic pain and musculoskeletal conditions, including specialty hand clinic patients. A subset experience active suicidal ideation or thoughts of self-harm at or around the time of their visit; however, epidemiological data are limited. We aimed to determine the prevalence of active suicidal ideation and hypothesized that hand surgery patients endorsing it would report greater pain, worse physical function, and greater socioeconomic disadvantage than those without suicidal ideation. Methods We conducted a retrospective review of patients presenting to our clinic from August 2022 to August 2023. They completed a Patient Health Questionnaire two-question (PHQ-2) screener; those scoring ≥3 completed the PHQ nine-question (PHQ-9). Active suicidal ideation (“high risk”) was defined as a nonzero response to item 9 of the PHQ-9. Demographic, socioeconomic (including Area Deprivation Index), and patient-reported outcome data were collected. Chi-squared and t tests were used to compare high- and low-risk patients, and multivariable regression was used to assess adjusted associations between surgical status and follow-up patterns. Results Of the 7,023 new patients who completed the PHQ-2, 495 (7%) screened positive and completed the PHQ-9; 123 patients (1.8% of total) endorsed active suicidal ideation. Compared with low-risk patients, high-risk patients reported significantly higher pain, poorer global physical health, and worse upper extremity function, along with greater socioeconomic disadvantages, including higher Area Deprivation Index scores and more frequent transportation barriers. No significant differences occurred in surgical rates or follow-up utilization between high- and low-risk patients, including after stratification by procedure type. Conclusions Approximately 1 in 50 new patients reported active suicidality, greater pain, worse physical function, and greater socioeconomic burden—differences that exceeded published minimal clinically important differences. Screening tools and targeted surgeon education may aid in early identification and guide opportunities for intervention and support. Type of study/level of evidence Prognostic IV.
Vascularized medial femoral condyle (MFC) flap transfer is a technique that may be used to reconstruct recalcitrant distal radius nonunion. Although union rates are high, the flap provides thin cortical bone requiring rigid fixation. The long-term strengthening and structural integrity of the MFC flap bone remains understudied. We describe two cases of delayed structural failure following distal radius MFC reconstruction. Two patients underwent distal radius reconstruction using vascularized corticocancellous MFC flaps stabilized with spanning fixed-angle volar plates. Both achieved radiographic union. Clinical records and radiographs were retrospectively reviewed following low-energy injuries. Late failure occurred 7 and 9 years after flap incorporation, involving deformity through the MFC bone segment. The spanning plates bent without evidence of screw loosening or hardware failure. These cases highlight a rare pattern of delayed structural failure following MFC reconstruction. Radiographic union alone may not predict long-term structural durability. Rigid fixed-angle fixation may influence load distribution and adaptive remodeling.
Purpose We sought to quantify care utilization, access to care, and cost for self-inflicted firearm injuries to the hand and wrist compared with violently inflicted injuries. We hypothesized that self-inflicted injuries would require equal or greater health care resources, representing a distinct population with unique barriers to care. Methods We performed a retrospective cohort study of adult patients with hand or wrist gunshot wounds treated at a single health system from 2015 to 2022. Demographic, treatment, access, and cost data were analyzed to compare self-inflicted and violent injury cohorts. Results A total of 244 injuries were included (162 violent and 82 self-inflicted). Patients with self-inflicted injuries were more likely to be older, employed, and White, whereas violently injured patients had higher area deprivation indices and Medicaid coverage. Self-inflicted injuries occurred more frequently in rural areas, required interfacility transfer, and were located farther from treating centers. Operative intervention was more common in self-inflicted injuries, with a higher number of procedures per patient. Physician charges billed and collected were significantly greater in the self-inflicted cohort. Over time, self-inflicted injuries represented an increasing proportion of cases, with increasing total and per-patient cost to treat these injuries. Conclusions Self-inflicted and violently inflicted firearm injuries represent distinct patient populations with different barriers to care. Both injury patterns create substantial economic impact, and self-inflicted injuries are associated with greater operative utilization and increasing financial burden, highlighting an underrecognized contributor to the cost of upper extremity trauma care. Type of study/level of evidence Economic/decision analysis III.
Background Patients with relapsed or refractory (R/R) follicular lymphoma (FL) after two or more prior lines of therapy can now be treated with mechanistically distinct modalities, including CD19-directed chimeric antigen receptor (CAR) T-cell therapy, CD20×CD3 bispecific antibodies, and a Bruton tyrosine kinase inhibitor plus anti-CD20 combination. Head-to-head data are lacking, and sequencing decisions are made with limited comparative evidence. We benchmarked durability outcomes across pivotal trials using reconstructed individual patient data (rIPD) derived from published Kaplan-Meier (KM) curves. Methods KM curves and numbers-at-risk tables from pivotal prospective studies in ≥2-line R/R FL were digitized and rIPD-reconstructed using a validated algorithm: axicabtagene ciloleucel (ZUMA-5), tisagenlecleucel (ELARA), lisocabtagene maraleucel (TRANSCEND FL), mosunetuzumab, epcoritamab (EPCORE NHL-1), and zanubrutinib plus obinutuzumab versus obinutuzumab (ROSEWOOD). Prespecified durability endpoints were landmark progression-free survival (PFS) at 12 and 24 months and restricted mean survival time to 24 months (RMST24). Overall survival (OS) landmarks were summarized where follow-up permitted. ROSEWOOD served as an internal validity check using a Cox model fit to reconstructed data. Results At 24 months, landmark PFS was 65.4% (95% confidence interval (CI) 52.0-82.4) for liso-cel, 62.0% (50.2-76.6) for axi-cel, 53.8% (45.2-63.9) for zanubrutinib plus obinutuzumab, 49.3% (39.3-61.7) for mosunetuzumab, 43.7% (31.3-61.1) for epcoritamab, and 24.7% (14.9-40.9) for obinutuzumab monotherapy. Twelve-month PFS ranged from 81.8% (74.5-89.8) with liso-cel and 77.9% (69.4-87.5) with axi-cel to 61.6% (53.6-70.8), 60.4% (50.8-72.0), and 59.1% (50.5-69.1) for zanubrutinib plus obinutuzumab, mosunetuzumab, and epcoritamab, respectively; tisagenlecleucel showed 12-month PFS of 68.3% (57.2-81.6) with shorter follow-up (maximum 18.2 months). PFS RMST24 estimates were 19.5 months for liso-cel, 18.6 for axi-cel, 16.5 for zanubrutinib plus obinutuzumab, 16.2 for mosunetuzumab, 14.8 for epcoritamab, and 11.9 for obinutuzumab. OS at 24 months was high across regimens (mosunetuzumab 87.3%, liso-cel 84.6%, axi-cel 82.8%, zanubrutinib plus obinutuzumab 77.3%, and epcoritamab 67.6%). In ROSEWOOD, reconstructed data reproduced the published PFS benefit for zanubrutinib plus obinutuzumab (hazard ratio (HR) 0.48, 95% CI 0.32-0.71; p < 0.001) with a weaker OS signal (HR 0.61, 0.35-1.07; p = 0.08). Conclusions In this rIPD-based durability benchmark for ≥2-line R/R FL, the estimated landmark PFS and RMST24 values varied across regimens, with numerically higher point estimates for the CAR T-cell therapies and the zanubrutinib plus obinutuzumab combination and numerically lower estimates for the bispecific antibodies and the obinutuzumab control; CIs overlapped substantially, and 24-month OS estimates were broadly similar across regimens. Because the source trials enrolled materially different populations, these side-by-side estimates are descriptive benchmarks and should not be read as head-to-head comparisons of efficacy. Faithful internal reproduction of the randomized ROSEWOOD effect supports reconstruction fidelity. The analysis provides a transparent, durability-focused reference framework to support sequencing discussions and hypothesis generation, not comparative effectiveness conclusions.
In many nerve injuries, tissue destruction, scar, and other factors prohibit surgical reapproximation of the nerve ends without excessive tension. The resultant nerve gap has traditionally been bridged using autologous sensory nerve; however, the harvest of autologous nerve graft adds time and donor site morbidity. Over the past decades, a variety of commercially available hollow conduits designed for nerve gap reconstruction have been used. More recently, commercially available processed human nerve allograft has been introduced with the promise of reconstruction whose success rivals the results of nerve autograft. In the case of digital nerve reconstructions, a number of studies indicate that for small nerve gaps (<15 mm) the recovery of sensation is the same for nerves repaired with nerve autograft, hollow nerve conduit, or processed nerve allograft. Although processed nerve allograft appears to outperform hollow conduits for slightly larger nerve gaps, it is unclear how it compares to nerve autograft across a variety of different nerve injuries. Overall, the results of nerve reconstruction are often disappointing, regardless of whether by direct repair or by spanning an intervening nerve gap. Further work on the biology of nerve regeneration is needed, not only to improve existing nerve conduits, but to improve the results of all nerve repairs and reconstructions.